Obesity
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
However, weak associations between HSD11B1 genotype, increased 11beta-HSD1 activity, and W:H ratio suggest that polymorphic variability at the HSD11B1 locus may influence susceptibility to central obesity through enhanced 11beta-HSD1 activity (E to F conversion) in visceral adipose tissue.
|
12414862 |
2002 |
Obesity
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The mechanism of this up-regulation remains uncertain; polymorphisms in the HSD11B1 gene have been associated with metabolic complications of obesity, including hypertension and type 2 diabetes, but not with obesity per se.
|
17343766 |
2007 |
Obesity
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
A novel SNP, rs3753519, was strongly associated with obesity and this SNP was the only statistically significant HSD11B1 gene SNP remaining after a Bonferroni correction (odds ratio=1.97 for allelic effect, 95% confidence interval 1.23-3.16; P=0.004 and Bonferroni corrected P=0.046).
|
22310475 |
2012 |
Obesity
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms in HSD11B1, the gene encoding 11β-hydroxysteroid dehydrogenase type 1 enzyme, have been associated with obesity, metabolic syndrome, and type 2 diabetes.
|
21117953 |
2011 |
Obesity
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Our objective was to investigate a functional polymorphism in HSD11B1 (T-->G in the third intron rs12086634, which associates with lower 11beta-HSD1 activity) in PCOS with and without obesity.
|
16551740 |
2006 |
Obesity
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
To investigate the relationship between 11β-hydroxysteroid dehydrogenase (HSD11B) gene type 1 and 2 and obesity in Chinese children.
|
24729284 |
2014 |
Obesity
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We confirmed that adipocyte 11beta-HSD1 mRNA concentrations were associated with adiposity, and showed that genetic variations in the HSD11B1 gene were associated with Type 2 diabetes mellitus, plasma insulin concentrations and insulin action, independent of obesity.
|
15156315 |
2004 |
Cortisone reductase deficiency
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
Recently, it was proposed that a combination of the 83,557insA polymorphism in the 11beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene and the R453Q polymorphism in the hexose-6-phosphate dehydrogenase (H6PD) gene interacts to cause cortisone reductase deficiency (CRD) when at least three alleles are affected.
|
17062770 |
2007 |
Cortisone reductase deficiency
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
Common polymorphisms in both HSD11B1 and the hexose-6-phosphate dehydrogenase (H6PD) gene encoding hexose-6-phosphate dehydrogenase have been found together in ACRD patients, who carry three of a possible four minor alleles at the two loci.
|
16091483 |
2005 |
Cortisone reductase deficiency
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
The R453Q variant in the hexose-6-phosphate dehydrogenase gene (H6PD) and 83557insA mutations in 11beta-hydroxysteroid dehydrogenase (11betaHSD) type 1 gene (HSD11B1) interact, resulting in cortisone reductase deficiency (CRD), a rare disorder characterized by a polycystic ovary syndrome (PCOS)-like phenotype.
|
15827106 |
2005 |
Cortisone reductase deficiency
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
Inactivating mutations in HSD11B1 cause true cortisone reductase deficiency (CRD).
|
23132696 |
2013 |
Hypertensive disease
|
0.380 |
GeneticVariation
|
group |
BEFREE |
Functional polymorphisms within 11beta-hydroxysteroid dehydrogenase Type 1 (HSD11B1) gene have shown an association with various factors, including insulin resistance (IR) and hypertension.
|
28750217 |
2017 |
Hypertensive disease
|
0.380 |
GeneticVariation
|
group |
BEFREE |
Regeneration of cortisol by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) within liver and adipose tissue may be of pathophysiological importance in obesity and the metabolic syndrome. single nucleotide polymorphisms (SNPs) in HSD11B1, the gene encoding 11β-HSD1, have been associated with type 2 diabetes and hypertension in population-based cohort studies, and with hyperandrogenism in patients with the polycystic ovary syndrome (PCOS).
|
21622477 |
2011 |
Hypertensive disease
|
0.380 |
GeneticVariation
|
group |
BEFREE |
We assessed the association between polymorphisms in the HSD11B1 gene and left ventricular mass (LVM) in 248 families ascertained through a proband with hypertension.
|
21402901 |
2011 |
Hypertensive disease
|
0.380 |
GeneticVariation
|
group |
BEFREE |
Polymorphisms in HSD11B1, the gene encoding 11 beta-HSD1, have been associated with metabolic phenotype in humans, including type 2 diabetes and hypertension.
|
19934376 |
2010 |
Mental Depression
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
This study aimed to assess whether HSD11B1 genotypes and haplotypes are associated with depression risk, severity of symptoms and suicidal attempts, considering early-life stress as an environmental factor.
|
31704233 |
2020 |
Mental Depression
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
The aim of our study was to identify polymorphisms in 11β-HSD1 gene (HSD11B1) with consistent associations with increased HPA axis activity and relate those polymorphisms to depression.
|
22112815 |
2012 |
Mental Depression
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Statistically significant findings at the 0.05 p-level included SNPs in the hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1) gene in relation to self-rated depression scores in postpartum week six among all participants, and serpin family A member 6 (SERPINA6) gene at the same time-point among women with de novo onset of postpartum depression.
|
30776573 |
2019 |
Depressive disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
This study aimed to assess whether HSD11B1 genotypes and haplotypes are associated with depression risk, severity of symptoms and suicidal attempts, considering early-life stress as an environmental factor.
|
31704233 |
2020 |
Depressive disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Statistically significant findings at the 0.05 p-level included SNPs in the hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1) gene in relation to self-rated depression scores in postpartum week six among all participants, and serpin family A member 6 (SERPINA6) gene at the same time-point among women with de novo onset of postpartum depression.
|
30776573 |
2019 |
Depressive disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
The aim of our study was to identify polymorphisms in 11β-HSD1 gene (HSD11B1) with consistent associations with increased HPA axis activity and relate those polymorphisms to depression.
|
22112815 |
2012 |
Malignant neoplasm of breast
|
0.320 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Malignant neoplasm of breast
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Two out of five tagging SNPs in HSD11B1 were associated with breast cancer (rs11807619, P = 0.006; rs932335, P = 0.0001). rs11807619 and rs932335 were highly correlated (r2 = 0.74) and, when modeled as a haplotype, only haplotypes containing the rs932335 C allele were associated with breast cancer.
|
18611262 |
2008 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The variations in HSD11B1 were not associated with susceptibility to type 2 diabetes or metabolic phenotypes in Koreans.
|
19571556 |
2009 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Regeneration of cortisol by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) within liver and adipose tissue may be of pathophysiological importance in obesity and the metabolic syndrome. single nucleotide polymorphisms (SNPs) in HSD11B1, the gene encoding 11β-HSD1, have been associated with type 2 diabetes and hypertension in population-based cohort studies, and with hyperandrogenism in patients with the polycystic ovary syndrome (PCOS).
|
21622477 |
2011 |